Atorvastatin Calcium
- Product NDC
- 60760-829
- 11-digit product format
- 607600829
- Labeler code
- 60760
- Product ID
- 60760-829_ef53a855-a5df-8e3e-e053-2a95a90a19f6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atorvastatin Calcium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- ST. MARY'S MEDICAL PARK PHARMACY
- Application
- ANDA076477
- Marketing category
- ANDA
- Marketing start
- 2022-11-08
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 60760-829 | D | Discontinued by firm | 2026-10-15 | ||
| excluded package | package | 60760-829 | 60760-829-30 | D | Discontinued by firm | 2026-10-15 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076477-001 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2011-11-30 | ||
| A076477-002 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2011-11-30 | ||
| A076477-003 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2011-11-30 | ||
| A076477-004 | ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2011-11-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2011-11-30 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2011-11-30 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2011-11-30 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2011-11-30 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2011-11-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2011-11-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2011-11-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2011-11-30 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2011-11-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2011-11-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2011-11-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2011-11-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2011-11-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2011-11-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2011-11-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2011-11-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2011-11-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2011-11-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2011-11-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2011-11-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | 2011-11-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | 2011-11-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | 2011-11-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | 2011-11-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2011-11-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2011-11-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2011-11-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2011-11-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2011-11-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2011-11-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2011-11-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2011-11-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2011-11-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2011-11-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2011-11-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2011-11-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076477-001 | ATORVASTATIN CALCIUM | EQ 10MG BASE | TABLET / ORAL | AB | 2011-11-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076477-002 | ATORVASTATIN CALCIUM | EQ 20MG BASE | TABLET / ORAL | AB | 2011-11-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076477-003 | ATORVASTATIN CALCIUM | EQ 40MG BASE | TABLET / ORAL | AB | 2011-11-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076477-004 | ATORVASTATIN CALCIUM | EQ 80MG BASE | TABLET / ORAL | AB | 2011-11-30 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-31 18:47 UTC | 2024-05 | A076477-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A076477-002 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A076477-003 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A076477-004 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076477-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076477-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076477-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076477-004 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A076477-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A076477-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A076477-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A076477-004 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A076477-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A076477-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A076477-003 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A076477-004 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A076477-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076477-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076477-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A076477-004 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A076477-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A076477-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A076477-003 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A076477-004 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A076477-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A076477-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A076477-003 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A076477-004 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076477-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076477-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076477-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076477-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A076477-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A076477-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A076477-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A076477-004 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A076477-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A076477-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A076477-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A076477-004 | AB | 1 | 8869cabd3fbd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60760-829-30 | EA - Each | 60760-829 | 0f2f7cfa-c481-4278-8440-b9a065cdfd6a | 1 | 2023-02-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Bryant Ranch Prepack | 2e583569-499d-4f20-87ca-84e7d9868d22 | 2026-07-14 | Warnings, Adverse reactions | 076477 ANDA076477 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Sun Pharmaceutical Industries Inc. | 595ab888-6b55-4642-a32f-e8521821ed81 | 2026-06-04 | Warnings, Adverse reactions | 076477 ANDA076477 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | NuCare Pharmaceuticals, Inc. | 49dcc58a-9f23-045d-e063-6394a90abda6 | 2026-02-02 | Warnings, Adverse reactions | 076477 ANDA076477 |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | DIRECT RX | c3b70f79-45a3-0869-e053-2a95a90a3cdb | 2025-01-20 | Warnings, Adverse reactions | 076477 ANDA076477 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Bryant Ranch Prepack | f7af3b3a-b73e-41ee-80e3-2be036672bb7 | 2024-08-22 | Warnings, Adverse reactions | 076477 ANDA076477 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | NuCare Pharmaceuticals,Inc. | b1a840cf-47aa-b931-e053-2a95a90a1047 | 2024-07-17 | Warnings, Adverse reactions | 076477 ANDA076477 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Bryant Ranch Prepack | bbb1a527-3b4d-4fd4-9e38-b231ad5d6d8f | 2024-05-30 | Warnings, Adverse reactions | 076477 ANDA076477 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Proficient Rx LP | d77e155c-403d-449e-bafd-11c9bd4974dd | 2020-01-01 | Warnings, Adverse reactions | 076477 ANDA076477 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 60760-829-30 | 60760082930 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-829-30) | 2022-11-08 | 0000-00-00 | No | No | Current |